tiprankstipranks
Trending News
More News >
Cogent Biosciences (COGT)
NASDAQ:COGT
US Market

Cogent Biosciences (COGT) Income Statement

Compare
719 Followers

Cogent Biosciences Income Statement

Last quarter (Q4 2025), Cogent Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Cogent Biosciences's net income was $-102.49M. See Cogent Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -4.62M$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 328.74M$ 275.94M$ 208.13M$ 147.84M$ 75.55M
Depreciation and Amortization
$ 4.62M$ 4.35M$ 3.59M$ 5.88M$ 1.99M
EBITDA
$ -328.74M$ -271.59M$ -204.54M$ -141.96M$ -73.56M
Operating Income
$ -333.36M$ -275.94M$ -208.13M$ -147.84M$ -75.55M
Other Income/Expenses
$ 4.43M$ 20.08M$ 15.72M$ 7.60M$ 3.28M
Pretax Income
$ -328.94M$ -255.86M$ -192.41M$ -140.24M$ -72.27M
Net Income
$ -328.94M$ -255.86M$ -192.41M$ -140.24M$ -72.27M
Per Share Metrics
Basic EPS
$ -2.55$ -2.46$ -2.42$ -2.26$ -1.85
Diluted EPS
$ -2.55$ -2.46$ -2.42$ -2.26$ -1.85
Weighted Average Shares Outstanding
67.60M 103.86M 79.66M 58.74M 38.73M
Weighted Average Shares Outstanding (Diluted)
67.60M 103.86M 79.66M 58.74M 38.73M
Currency in USD

Cogent Biosciences Earnings and Revenue History